Therefore, no correlation could be generated with patient survival using differential expression of TMEM230 in GBM (p-value 0.8494, Figure 6) as almost all patients with GBM expressed very high levels of TMEM230 and almost all patients had low survival after 4 years (1500 days). Here, TMEM230 is linked to glioblastoma.